← Open Payments lookup

JONATHAN MCCRARY: Open Payments

NPI 1962972968 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,169 in 113 payments from 22 companies in 2025. Trend: 2023 $2,898 · 2024 $2,790 · 2025 $2,169

Food & beverage: $2,169
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.13$258
Madrigal Pharmaceuticals10$224
ABBVIE INC.15$216
QOL Medical, LLC7$154
Ardelyx, Inc.7$142
Ipsen Biopharmaceuticals, Inc7$141
Aimmune Therapeutics, Inc.7$118
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$116
GENZYME CORPORATION5$113
Lilly USA, LLC6$112

Products named: ENTYVIO, REZDIFFRA, DUPIXENT, Sucraid, IBSRELA, IQIRVO, TREMFYA, ZENPEP.

Industry payments across AL — which companies pay providers there.